Prelude Capital Management’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-434
Closed -$271K 1136
2020
Q4
$271K Buy
+434
New +$271K 0.01% 553